Moreover, the CRP level correlated significantly with the tumor stage: 73.7% of all patients with CRP >15 and 36.7% of those with CRP ≤15 mg/l suffered from locally advanced (pT≥2) penile cancer (p<0.007, Fisher’s exact test). This evidence concerns the gene CRP and penile cancer.